Timothy Reilly

640 total citations
23 papers, 441 citations indexed

About

Timothy Reilly is a scholar working on Oncology, Nephrology and Molecular Biology. According to data from OpenAlex, Timothy Reilly has authored 23 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Nephrology and 4 papers in Molecular Biology. Recurrent topics in Timothy Reilly's work include Acute Kidney Injury Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Timothy Reilly is often cited by papers focused on Acute Kidney Injury Research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Chronic Kidney Disease and Diabetes (3 papers). Timothy Reilly collaborates with scholars based in United States, United Kingdom and Sweden. Timothy Reilly's co-authors include Nicholas M. Selby, Cynthia Ju, Maarten W. Taal, Nitin Kolhe, Richard Fluck, John Monaghan, Christopher W. McIntyre, Janson C. H. Leung, Will Jackson and Victoria Vazquez and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Timothy Reilly

21 papers receiving 429 citations

Peers

Timothy Reilly

NEPHR

EPIDE

CCICM

SURGE

Bnar Talabani United Kingdom

Brandon Savage United States

Lowell J. Lo United States

Katsuomi Matsui Japan

Rajiv N. Thakkar United States

Karina Soto Portugal

Jennie Lin United States

Chenfei Zheng China

Xiangjie Duan China

Yohei Komaru Japan

Bnar Talabani United Kingdom

Timothy Reilly

262 ×1.0

NEPHR

102 ×1.1

48 ×0.6

EPIDE

58 ×1.0

CCICM

41 ×0.9

SURGE

Citations per year, relative to Timothy Reilly Timothy Reilly (= 1×) peers Bnar Talabani

Countries citing papers authored by Timothy Reilly

Since Specialization

Citations

This map shows the geographic impact of Timothy Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Reilly more than expected).

Fields of papers citing papers by Timothy Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Reilly. The network helps show where Timothy Reilly may publish in the future.

Co-authorship network of co-authors of Timothy Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Reilly. A scholar is included among the top collaborators of Timothy Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Reilly. Timothy Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sanborn, Rachel E., Minal Patel, Jordi Rodón, et al.. (2024). 991O First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors. Annals of Oncology. 35. S675–S676. 1 indexed citations

Hörner, Daniela Viramontes, John Monaghan, Susan E. Shaw, et al.. (2023). A comprehensive description of kidney disease progression after acute kidney injury from a prospective, parallel-group cohort study. Kidney International. 104(6). 1185–1193. 24 indexed citations

Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2023). Abstract LB337: Inhibition of the E3 ligase CBL-B enhances the effector function and proliferation of natural killer cells. Cancer Research. 83(8_Supplement). LB337–LB337. 1 indexed citations

Luke, Jason J., Rachel E. Sanborn, Jordi Rodón, et al.. (2023). Abstract CT251: Phase 1/2 study of HST-1011, an oral CBL-B inhibitor, alone and in combination with anti-PD1 in patients with advanced solid tumors. Cancer Research. 83(8_Supplement). CT251–CT251. 2 indexed citations

Qi, Yilin, Jun Kuai, Yingzhi Bi, et al.. (2022). 424 An allosteric, orally administered CBL-B inhibitor remodels the tumor microenvironment and enhances immune-mediated tumor growth inhibition. Regular and Young Investigator Award Abstracts. A445–A445.

Reilly, Timothy, et al.. (2022). Moral and Intellectual Virtues in Practices. 2 indexed citations

Monaghan, John, et al.. (2017). Three-year outcomes after acute kidney injury: results of a prospective parallel group cohort study. BMJ Open. 7(3). e015316–e015316. 75 indexed citations

Vazquez, Victoria, et al.. (2017). Completeness, accuracy, and readability of Wikipedia as a reference for patient medication information. Journal of the American Pharmacists Association. 57(2). 197–200.e1. 20 indexed citations

Brunetti, Luigi, et al.. (2017). Comparison of Two Versions of the Beers Criteria and Adverse Outcomes in Older Hospitalized Patients. The Consultant Pharmacist. 32(12). 752–763. 5 indexed citations

10.

Kolhe, Nitin, Timothy Reilly, Janson C. H. Leung, et al.. (2016). A simple care bundle for use in acute kidney injury: a propensity score-matched cohort study. Nephrology Dialysis Transplantation. 31(11). 1846–1854. 73 indexed citations

11.

Reilly, Timothy, et al.. (2016). Accuracy and completeness of drug information in Wikipedia medication monographs. Journal of the American Pharmacists Association. 57(2). 193–196.e1. 8 indexed citations

12.

Kolhe, Nitin, Timothy Reilly, Christopher W. McIntyre, et al.. (2015). Impact of Compliance with a Care Bundle on Acute Kidney Injury Outcomes: A Prospective Observational Study. PLoS ONE. 10(7). e0132279–e0132279. 99 indexed citations

13.

Xu, Haiyan, Frances Jourd’heuil, Timothy Reilly, et al.. (2015). Nitric Oxide-Dependent and Independent Apoptosis Is Inhibited by Cytoglobin in Vascular Smooth Muscle. Free Radical Biology and Medicine. 87. S60–S60. 1 indexed citations

14.

Monaghan, John, et al.. (2014). The Effects of Acute Kidney Injury on Long-Term Renal Function and Proteinuria in a General Hospitalised Population. Nephron Clinical Practice. 128(1-2). 192–200. 19 indexed citations

15.

Ju, Cynthia & Timothy Reilly. (2012). Role of immune reactions in drug-induced liver injury (DILI). Drug Metabolism Reviews. 44(1). 107–115. 49 indexed citations

16.

Reilly, Timothy, et al.. (2012). Role of the Pharmacist on a General Medicine Acute Care for the Elderly Unit. The American journal of geriatric pharmacotherapy. 10(2). 95–100. 15 indexed citations

17.

Reilly, Timothy, et al.. (2010). Pitavastatin (Livalo) for Hyperlipidemia And Mixed Dyslipidemia: A Novel Therapeutic Agent, or a ‘Me-Too’ Drug?. Europe PMC (PubMed Central). 35(4). 197–207. 1 indexed citations

18.

Newland, Adrian C., Jamie Cavenagh, A. Copplestone, et al.. (2001). Vigam‐S, a solvent/detergent‐treated intravenous immunoglobulin, in idiopathic thrombocytopenic purpura. Transfusion Medicine. 11(1). 37–44. 15 indexed citations

19.

Moran, Kevin T., et al.. (1989). Autoantibody Formation in Burn Patients after Inhibition of Suppressor T Cell Activity with Polymyxin B. Journal of Burn Care & Rehabilitation. 10(3). 213–215. 2 indexed citations

20.

Reilly, Timothy. (1988). Sport, leisure and ergonomics. Applied Ergonomics. 19(2). 168–168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact